Updates - News - 傲流医疗

中文 / English

all

2024

2023

2022

2021

2020

News

All Updates Industry Information Medical Information

all

2023

2022

2021

2020

...

January 03,2024 • Latest News

The kick-off meeting of the world's first multi-center registered clinical trial of atrial septal shunt for pulmonary arterial hypertension was successfully held!

On the afternoon of January 3, 2024, the kick-off meeting of FreeFlow Percutaneous Atrial Septal Shunt Registration Clinical Research was held in Zhon...

View More
March 12,2024 • Latest News

Medical-Industrial Integration, Commuting in Both Directions | ConFlow MedTech was invited to participate in the fourth Fudan Zhongshan Patent Salon

On the afternoon of December 21st, the fourth Fudan Zhongshan Patent Salon was held in Zhongshan Hospital affiliated to Fudan University. The theme of...

View More
October 17,2023 • Latest News

Good News | ConFlow MedTech Appearing on the “2023 China Biomedical Front-Runners 100 List”

On October 17, 2023, the "2023 BioShanghai Biomedical Industry Investment Forum and Future Medical Industry Forum" was held in Minhang Fund ...

View More
September 18,2023 • Latest News

Thank you for being with us as we celebrate the third anniversary of ConFlow MedTech's establishment!

From September 10th to 13th, under the clear autumn sky with crisp air, all ConFlow MedTech team members assembled in picturesque Guilin, Guangxi prov...

View More
August 16,2023 • Latest News

Novel Approach for Alleviating Pulmonary Arterial Hypertension: Academician Ge Junbo and Professor Zhou Daxin's Team Utilize FreeFlow® in Clinical Research – Unveiling 1-Year Follow-Up Findings.

On May 25, 2022, a team led by Academician Ge Junbo and Director Zhou Daxin at Zhongshan Hospital Affiliated to Fudan University applied the FreeFlow&...

View More
July 24,2023 • Latest News

Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City

The Shanghai Municipal Commission of Economy and Information Technology has officially unveiled its "2023 Roster of Specialized and Sophisticated...

View More

上一页 1 2 3 4 下一页

Pride in progress,
Pursue further excellence!